259 related articles for article (PubMed ID: 26582459)
1. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
4. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
5. Role of protein kinase B in Alzheimer's neurofibrillary pathology.
Pei JJ; Khatoon S; An WL; Nordlinder M; Tanaka T; Braak H; Tsujio I; Takeda M; Alafuzoff I; Winblad B; Cowburn RF; Grundke-Iqbal I; Iqbal K
Acta Neuropathol; 2003 Apr; 105(4):381-92. PubMed ID: 12624792
[TBL] [Abstract][Full Text] [Related]
6. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
Hyman BT; Elvhage TE; Reiter J
Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
[TBL] [Abstract][Full Text] [Related]
8. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
[TBL] [Abstract][Full Text] [Related]
9. Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
Klingebiel M; Dinekov M; Köhler C
Brain Res; 2017 Mar; 1659():121-135. PubMed ID: 28119058
[TBL] [Abstract][Full Text] [Related]
10. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
12. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of tumor-suppressor PTEN in Alzheimer neurofibrillary tangles.
Sonoda Y; Mukai H; Matsuo K; Takahashi M; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2010 Feb; 471(1):20-4. PubMed ID: 20056128
[TBL] [Abstract][Full Text] [Related]
14. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
[TBL] [Abstract][Full Text] [Related]
15. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites.
Trojanowski JQ; Mawal-Dewan M; Schmidt ML; Martin J; Lee VM
Brain Res; 1993 Aug; 618(2):333-7. PubMed ID: 8374766
[TBL] [Abstract][Full Text] [Related]
16. Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains.
Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):817-30. PubMed ID: 23421764
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase II alteration precedes tau accumulation in tangle formation.
Masliah E; Iimoto DS; Mallory M; Albright T; Hansen L; Saitoh T
Am J Pathol; 1992 Feb; 140(2):263-8. PubMed ID: 1739121
[TBL] [Abstract][Full Text] [Related]
18. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.
Pearson AG; Byrne UT; MacGibbon GA; Faull RL; Dragunow M
Neurosci Lett; 2006 May; 398(3):246-50. PubMed ID: 16481106
[TBL] [Abstract][Full Text] [Related]
19. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
Yan T; Wang L; Gao J; Siedlak SL; Huntley ML; Termsarasab P; Perry G; Chen SG; Wang X
J Alzheimers Dis; 2018; 63(1):157-165. PubMed ID: 29562525
[TBL] [Abstract][Full Text] [Related]
20. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains.
Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y
Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]